Abstract
BackgroundRecent studies have demonstrated that earlier time-of-day infusion of immune checkpoint inhibitors (ICIs) is associated with longer progression-free survival (PFS) and overall survival (OS) among patients with metastatic melanoma and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have